30
Participants
Start Date
February 6, 2023
Primary Completion Date
June 30, 2027
Study Completion Date
August 31, 2027
Stable isotope infusion, oral glucose ingestion, intravenous arginine bolus
On separate study days, each participant will have a stable isotope infusion, ingest oral glucose, and be given an intravenous arginine bolus.
RECRUITING
Texas Children's Hospital / Baylor College of Medicine, Houston
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Baylor College of Medicine
OTHER